Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT07238556 · Hypertension, Dyslipidemia, and more
NCT06772168 · Dyslipidemia, Type 2 Diabetes
NCT06380322 · Hypertension, Type 2 Diabetes, and more
NCT06314919 · Primary Hypercholesterolemia, Mixed Dyslipidemia
NCT07162441 · Dyslipidemia
Harrell, Robert
Little Rock, Arkansas
Cetero Research - San Antonio
San Antonio, Texas
Local Institution
Blacktown, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions